Cat. No. | Product name | CAS No. |
DC10780 |
ALB-127158(a)
Featured
ALB-127158A, also known as ALB-127158(a), is a MCH1 antagonist for the treatment of obesity. |
1173154-32-9 |
DCAPI1243 |
Albendazole(Albenza)
Albendazole(Albenza) |
54965-21-8 |
DC20174 |
Albiglutide
Featured
Albiglutide is a glucagon-like peptide-1 agonist (GLP-1 agonist). |
782500-75-8 |
DC21993 |
ALDH1A inhibitor 673A
ALDH1A inhibitor 673A (ALDH1Ai 673A) is a potent, selective, pan-ALDH1A inhibitor with IC50 of 246, 230 and 348 nM for ALDH1A1, ALDH1A2 and ALDH1A3, respectively. |
109437-62-9 |
DC20653 |
ALE-0540
Featured
ALE-0540 is a nerve growth factor (NGF) antagonist that inhibits the binding of NGF to TrkA or both p75 and TrkA with IC50 of 5.88 and 3.72 uM, respectively. |
234779-34-1 |
DCAPI1034 |
Alendronate (Fosamax)
Alendronate (Fosamax) |
121268-17-5 |
DC22492 |
Alexamorelin
Featured
Alexamorelin is a synthetic growth hormone (GH) secretagogue. |
196808-85-2 |
DC12389 |
Alflutinib
Featured
Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor, inhibits EGFR active mutations as well as T790M acquired resistant mutation.The Alflutinib free base form is not stable, so we make it the mesylate s |
1869057-83-9 |
DC22211 |
ALG1001 (Risuteganib)
Featured
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis; ALG1001 inhibits an integrin-mediated pathway of the vitreoretinal interface, connecting the posterior aspect of the vitreous with the internal limiting membrane of the retina. In blocking this pathway, ALG-1001 helps to achieve vitreous breakdown and separation from the retina. |
1307293-62-4 |
DC20056 |
Alicapistat (ABT-957)
Alicapistat (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential use in the treatment of Alzheimer's disease (AD). |
1254698-46-8 |
DC23405 |
Alizapride
Alizapride (MS 5080) is a dopamine D2 antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting.. |
59338-93-1 |
DC23489 |
Alizapride hydrochloride
Alizapride (MS 5080) is a dopamine D2 antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting.. |
59338-87-3 |
DC23092 |
Alizarin
Alizarin has a selective and effective inhibitory activity towards cancerous cells, it acts through the inhibition of ERK phosphorylation and cell cycle arrest in the S-phase. |
72-48-0 |
DC9338 |
ALK inhibitor 1
Featured
ALK inhibitor 1 is a novel and selective inhibitor for the ALK kinase. |
761436-81-1 |
DC9339 |
ALK inhibitor 2
Featured
ALK inhibitor 2 is a novel and selective inhibitor for the ALK kinase. |
761438-38-4 |
DC10582 |
Diroximel Fumarete(ALKS-8700)
Featured
ALKS-8700 also known as diroximel fumarate, is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body. |
1577222-14-0 |
DC21668 |
ALLO-2
Featured
ALLO-2 is a potent small molecule Smoothened (Smo) antagonist that inhibits Smo agonist Hh-Ag1.5-induced luciferase expression in TM3-Gli-Luc cells with IC50 of 6 nM. |
1357350-60-7 |
DC12226 |
Alloepipregnanolone
Alloepipregnanolone, a pregnane with anesthetic, hypnotic, and sedative properties, interferes with the development of rapid tolerance to the anxiolytic effect of ethanol. |
516-55-2 |
DC8945 |
Allopurinol
Allopurinol (Zyloprim) is a xanthine oxidase inhibitor with an IC50 of 7.82±0.12 μM. |
315-30-0 |
DCAPI1097 |
Allopurinol Sodium (Aloprim)
Featured
Allopurinol sodium is a potent xanthine oxidase inhibitor (IC50 values of 0.2 to 50 μM). Allopurinol sodium can be used for the research of hyperuricemia and gout. Antileishmanial effect[1][2]. |
17795-21-0 |
DC20171 |
Alloxazine;Isoalloxazine
Alloxazine is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor. |
490-59-5 |
DC12060 |
all-trans-4-Oxoretinoic acid
all-trans-4-Oxoretinoic acid, an active metabolite of vitamin A, induces gene transcription via binding to nuclear retinoic acid receptors (RARs). |
38030-57-8 |